Personalized Dosage Form Design (PersDrug)
We aim to design new dosage forms and innovative technological solutions to fulfill the potential of personalized medicine for individuals or groups of individuals.
Traditionally, most medical treatments have been designed for the "average patient" under the assumption that "one size fits all". Recent breakthrough in fields of diagnostics, genotyping and biomarkers enable the development of more tailor-made personalized solutions.
In the era of Personalized Medicine limited attention has so far been given to the development of dosage forms and formulations that are able to deliver requirements for optimal personalized therapy.
The research projects spans from pharmaceutical technology, formulations and process optimization (including physico-chemical and biopharmaceutical characteristics) to the assessment of potential risks of not-optimal solutions in a clinical context.
Central technologies and delivery systems
- Professor Natasa Skalko-Basnet, Department of Pharmacy, UiT The Arctic University of Norway
- Ass. Professor Željka Vanić, Faculty of Pharmacy and Biochemistry, University of Zagreb, Kroatia
- Professor Ganesh Acharya and professor Purusotam Basnet, University Hospital of North Norway/UiT
- Senior scientist Dr. Ellen Bruzell, Nordic Institute of Dental Materials (NIOM)
- Professor Niklas Sandler, Åbo Akademi University, Finland
- Dr. Sofia Mattsson, Umeå University, Sverige
- Senior researcher Dr. Siri Wang, Statens Legemiddelverk
- Hospital pharmacist Ingrid Grønlie, Medicines for Children Network, Norway
- Researcher Dr. Jørgen Brustugun, Hospital Pharmacy Rikshospitalet
- Dr. Kathrin Bjerknes, Hospital Pharmacy Lørenskog